Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 2.895
+0.025 (0.87%)
Sep 25, 2026, 10:25 AM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 217.46 million as of September 24, 2026. Its market cap has decreased by -30.40% in one year.
Market Cap
217.46M
Enterprise Value
299.79M
Revenue
42.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.90
ChartMarket Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 217.46M, an increase of 51.01%. That is a compound annual growth rate of 2.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 217.46M | -15.81% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 646.65M |
| Captor Therapeutics Spolka Akcyjna | 451.73M |
| Bioceltix | 416.58M |
| Ryvu Therapeutics | 369.92M |
| BIOTON | 310.40M |
| Molecure | 159.67M |
| Mabion | 126.07M |
| Poltreg | 120.10M |